| Condition | Key Finding | Association | Board Exam Tip |
| Telogen Effluvium | Diffuse hair thinning; non-patchy loss | Major physiological stress (e.g., surgery, rapid weight loss, MI) | Prognosis is excellent and self-limited; the scalp/follicles are intact. |
| Anterior Uveitis (AIV) | Pain, redness, ciliary flush, photophobia | Idiopathic; IBD; Seronegative spondyloarthropathies | Always consider idiopathic as the most common cause if no clear systemic link is given. |
| HAND | Cognitive decline, mood swings | Low CD4 count (<200 cells/mm³) | The low CD4 count, not age or duration of HIV, is the primary risk factor for severe neurocognitive impairment. |
| Amlodipine (Dihydropyridine CCB) | Peripheral edema | Arteriolar dilation -> increased capillary hydrostatic pressure | To treat peripheral edema caused by vasodilators, use an ACE inhibitor to dilate post-capillary venules. |
| Topic | Key Point | Context | Exam Relevance |
| Prevention Levels | Primary: Prevent onset; Secondary: Screen early; Tertiary: Minimize damage/worsening | Hearing conservation program (Screening) vs. N95 mask (Preventing exposure). | Requires analyzing the goal of the intervention in the scenario provided. |
| Telogen Effluvium | Diffuse, acute hair loss; self-limited prognosis | Stressors: Surgery, MI, severe infection, rapid weight loss. | The USMLE loves blending this with GLP-1 agonists (rapid weight loss). |
| Biostatistics | Cross-sectional study = Snapshot in time | Only provides prevalence data. Cannot determine incidence or risk over time. | Trap question: Never assume a cross-sectional study can measure new cases (incidence). |
| Amlodipine/AC Ei Interaction | CC Bs dilate arterioles; AC Eis dilate venules | Amlodipine causes peripheral edema by increasing capillary hydrostatic pressure. | The counterintuitive fix is to use an ACE inhibitor to reduce the back-pressure in the venous system. |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient with a history of steroid use presents with acute unilateral eye pain, redness, and ciliary flush. | Anterior Uveitis (AIV) | Steroid exposure is a major risk factor for AIV; the presentation is classic for inflammation of the anterior chamber. |
| A patient develops diffuse hair thinning following rapid weight loss due to GLP-1 agonist therapy. | Telogen Effluvium | Significant physiological stress (e.g., caloric restriction, surgery) triggers this condition, which resolves spontaneously. |
| A patient with HIV presents with cognitive decline and mood swings, and their CD4 count is <200 cells/mm³. | HAND | Low CD4 count is the strongest predictor of neurocognitive impairment; distinguishing it from Alzheimer's is a key exam trap. |
| The study design measures the proportion of individuals with hypertension at one specific point in time. | Cross-sectional study (Prevalence) | This method provides a "snapshot" and can only calculate prevalence, not incidence or risk over time. |
| A patient taking an alpha-1 blocker for BPH develops syncope while also taking amlodipine. | Hypotension/Orthostasis | The combination of two vasodilators (alpha-blocker + CCB) leads to excessive systemic vasodilation and reduced blood pressure. |
| A monoclonal antibody is used to block the RANK ligand, preventing osteoclast activation in a patient with hypercalcemia. | Denosumab (RANKL inhibitor) | Denosumab specifically targets the pathway that activates osteoclasts, making it useful for treating malignancy-associated bone disease. |
| Key Features | Distinguishing Findings | Next Step |
| Cognitive decline, mood swings, behavioral changes. | HAND is strongly correlated with low CD4 count (<200 cells/mm³). | Measure CD4 count; initiate Antiretroviral Therapy (ART) if poorly controlled. |
| Key Features | Distinguishing Findings | Next Step |
| Stratification: Dividing the population into subgroups based on a confounder. | Done during the analysis phase of the study. | Use this method when confounding is suspected and cannot be controlled by design. |
| Randomization: Assigning participants to groups purely by chance. | Done during the selection/design phase of the study. | This is the gold standard for minimizing selection bias and balancing confounders across groups. |
| Condition | Association | Mechanism | Clinical Significance |
| Telogen Effluvium | Stressors/Physiological shock | Telogen phase prematurely triggered by systemic stress. | Requires no specific treatment; prognosis is excellent and self-limited. |
| Amlodipine (CCB) | Peripheral Edema | Arteriolar dilation increases capillary hydrostatic pressure. | ACE inhibitors can be used adjunctively to reduce this pressure by dilating post-capillary venules. |
| Denosumab | Hypercalcemia of Malignancy | Monoclonal antibody against RANK ligand, preventing osteoclast activation. | Effective alternative to bisphosphonates for treating bone resorption in cancer. |
| Cross-sectional Study | Prevalence calculation | Measures the proportion of cases existing at a single point in time (snapshot). | Cannot determine incidence or risk; use cohort studies for longitudinal data. |
| Term | Definition | Context | Example |
| Telogen Effluvium | Diffuse, acute hair shedding due to physiological stress. | Hair loss following major stressors like surgery, MI, or rapid weight loss. | A patient who lost 20 lbs in two months and now has diffuse thinning. |
| HAND | HIV Associated Neurocognitive Disorder. | Cognitive decline/mood changes in immunocompromised patients with HIV. | Differentiating HAND from Alzheimer's requires checking the CD4 count. |
| Cross-sectional Study | A study that measures exposure and outcome simultaneously at one point in time. | Biostatistics; used to calculate prevalence but not incidence. | Surveying blood pressure levels across a community today. |
| Iridocyclitis | Alternative name for Anterior Uveitis (AIV). | Ophthalmology/Inflammation; recognizing synonyms is crucial on exams. | A patient presenting with acute eye pain and redness, regardless of the specific term used. |
| Topic | Study Approach | Priority | Resources |
| Biostatistics | Focus on what can be measured (Prevalence vs. Incidence) and when interventions occur (Randomization vs. Stratification). | High | Reviewing the definitions of observational studies (Cohort, Case-Control, Cross-sectional). |
| Pharmacology | Master mechanisms of action and associated side effects/countermeasures for major drug classes (CC Bs, Alpha-blockers, RANKL inhibitors). | Medium-High | Creating flowcharts: Drug A -> Action -> Side Effect -> Countermeasure. |
| Clinical Syndromes | Create a differential diagnosis list for common presentations (e.g., Uveitis, Hair Loss) and memorize the most likely/classic cause tested on exams. | High | Reviewing classic vignettes: Steroid use + Eye pain = AIV. |